{"transactions":[{"id":2669899,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":173145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the Reporting Person's separation agreement dated December 21, 2020, the Compensation Committee accelerated the vesting of such stock options to December 29, 2020."}],"balance_after":477870,"derivative":{"exercise_price":2.6,"exercise_date":"2020-12-29","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":173145},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669898,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":298320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the Reporting Person's separation agreement dated December 21, 2020, the Compensation Committee accelerated the vesting of such stock options to December 29, 2020."}],"balance_after":477870,"derivative":{"exercise_price":2.48,"exercise_date":"2020-12-29","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":298320},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669897,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":477870,"derivative":{"exercise_price":21.6,"exercise_date":"2019-01-23","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":755},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669896,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":477870,"derivative":{"exercise_price":51.84,"exercise_date":"2018-10-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669895,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":477870,"derivative":{"exercise_price":5.18,"exercise_date":"2017-01-04","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669894,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."}],"balance_after":477870,"derivative":{"exercise_price":7.18,"exercise_date":"2016-03-17","expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":223},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2669893,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2021-06-14T16:10:39.000Z","date":"2021-06-10","kind":"other","acquired":true,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Expiration date of the stock options was extended to June 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"7,338 of the stock options vest immediately.  4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017."}],"balance_after":477870,"derivative":{"exercise_price":447.84,"expiration_date":"2023-06-10","underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0001628280-21-012169","document":"wf-form4_162370142446711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000162828021012169/wf-form4_162370142446711.xml","form_type":"4"}},{"id":2702769,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-20T16:33:46.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan."}],"balance_after":291050,"derivative":{"exercise_price":1.7,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-21-069934","document":"tm2117144-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465921069934/tm2117144-1_4seq1.xml","form_type":"4"}},{"id":3049734,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-08-21T16:16:58.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91050,"derivative":{"exercise_price":3.72,"exercise_date":"2021-08-19","expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-097598","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920097598/a4.xml","form_type":"4"}},{"id":3104130,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Options","published_at":"2020-06-19T16:15:19.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":173145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"57,715 vest on each of June 17, 2021, 2022 and 2023."}],"balance_after":477870,"derivative":{"exercise_price":2.6,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":173145},"source":{"system":"sec-edgar","filing":"0001104659-20-075230","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920075230/a4.xml","form_type":"4"}},{"id":3145190,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T16:15:27.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":13986,"price":1.43,"value":19999.98,"ownership":{"direct":true},"balance_after":18875,"source":{"system":"sec-edgar","filing":"0001104659-20-063173","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920063173/a4.xml","form_type":"4"}},{"id":3180466,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-04-07T16:15:11.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61051,"derivative":{"exercise_price":1.63,"exercise_date":"2021-04-03","expiration_date":"2030-04-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-20-044175","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465920044175/a4.xml","form_type":"4"}},{"id":3455920,"issuer":{"id":8208,"kind":"organization","name":"Hepion Pharmaceuticals, Inc.","symbol":"HEPA"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-07-25T16:15:38.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1051,"derivative":{"exercise_price":3.24,"exercise_date":"2019-07-24","expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":970},"source":{"system":"sec-edgar","filing":"0001104659-19-041845","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465919041845/a4.xml","form_type":"4"}},{"id":3479948,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2019-06-24T16:07:17.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":298230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"99,410 vest on each of June 20, 2020, 2021 and 2022."}],"balance_after":304725,"derivative":{"exercise_price":2.48,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":298230},"source":{"system":"sec-edgar","filing":"0000899243-19-017922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000089924319017922/doc4.xml","form_type":"4"}},{"id":3871695,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-07-06T16:31:32.000Z","date":"2018-07-03","kind":"exercise","acquired":false,"shares":100023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options became exercisable on 7/9/2009 and 7/9/2010."}],"balance_after":434223,"derivative":{"exercise_price":0.5,"expiration_date":"2018-07-09","underlying":"Common Stock","underlying_shares":100023},"source":{"system":"sec-edgar","filing":"0001104659-18-044168","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465918044168/a4.xml","form_type":"4"}},{"id":3871694,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:31:32.000Z","date":"2018-07-03","kind":"tax_withholding","acquired":false,"shares":27785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares forfeited to the Company in payment of the exercise price of the stock options."}],"balance_after":72238,"source":{"system":"sec-edgar","filing":"0001104659-18-044168","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465918044168/a4.xml","form_type":"4"}},{"id":3871693,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:31:32.000Z","date":"2018-07-03","kind":"exercise","acquired":true,"shares":100023,"price":0.5,"value":50011.5,"ownership":{"direct":true},"balance_after":100023,"source":{"system":"sec-edgar","filing":"0001104659-18-044168","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465918044168/a4.xml","form_type":"4"}},{"id":3888346,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-19T16:31:37.000Z","date":"2018-06-16","kind":"grant","acquired":true,"shares":114750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of stock options to each outside independent board member of the issuer."}],"balance_after":534246,"derivative":{"exercise_price":1.8,"exercise_date":"2019-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":114750},"source":{"system":"sec-edgar","filing":"0001104659-18-041065","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465918041065/a4.xml","form_type":"4"}},{"id":4089594,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-01-25T17:00:25.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":54322,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":467277,"derivative":{"exercise_price":0.3,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":54322},"source":{"system":"sec-edgar","filing":"0000899243-18-001900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000089924318001900/doc4.xml","form_type":"4"}},{"id":4107124,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-04T17:15:52.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. The common stock into which such vested restricted stock units converted on January 2, 2018 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-18-000483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000089924318000483/doc4.xml","form_type":"4"}},{"id":4107123,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T17:15:52.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 16,667 restricted stock units, all of which vested on January 2, 2018. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":351959,"source":{"system":"sec-edgar","filing":"0000899243-18-000483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000089924318000483/doc4.xml","form_type":"4"}},{"id":4190901,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-10-05T16:18:13.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":38106,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":412955,"derivative":{"exercise_price":0.72,"exercise_date":"2018-10-04","expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":38106},"source":{"system":"sec-edgar","filing":"0001104659-17-061150","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917061150/a4.xml","form_type":"4"}},{"id":4215783,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-09-06T20:45:29.000Z","date":"2017-09-02","kind":"exercise","acquired":false,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. The common stock into which such vested restricted stock units converted on September 2, 2017 is reported in Table I on this Form 4."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":8806},"source":{"system":"sec-edgar","filing":"0001104659-17-055892","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917055892/a4.xml","form_type":"4"}},{"id":4215782,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-06T20:45:29.000Z","date":"2017-09-02","kind":"exercise","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units into common stock (the \"Converted Common Stock\"). On January 2, 2017, the reporting person was granted 8,806 restricted stock units, all of which vested on September 2, 2017. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 5, 2017."}],"balance_after":335292,"source":{"system":"sec-edgar","filing":"0001104659-17-055892","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917055892/a4.xml","form_type":"4"}},{"id":4269089,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:09:23.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":420496,"derivative":{"exercise_price":1.4,"exercise_date":"2017-06-28","expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001104659-17-043014","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917043014/a4.xml","form_type":"4"}},{"id":4269088,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:09:23.000Z","date":"2017-06-28","kind":"disposition_to_issuer","acquired":false,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":409746,"derivative":{"exercise_price":1.4,"expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001104659-17-043014","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917043014/a4.xml","form_type":"4"}},{"id":4269087,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:09:23.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":420496,"derivative":{"exercise_price":4.5,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-17-043014","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917043014/a4.xml","form_type":"4"}},{"id":4498062,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T16:58:56.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest on September 2, 2017."}],"balance_after":25473,"derivative":{"underlying":"Common Stock","underlying_shares":8806},"source":{"system":"sec-edgar","filing":"0001104659-17-000963","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917000963/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4498061,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-05T16:58:56.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000963","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917000963/a4a.xml","form_type":"4/A","original_submission_date":"2017-01-04"}},{"id":4502117,"issuer":{"id":6917,"kind":"organization","name":"Cardiff Oncology, Inc."},"owners":[{"id":138286,"kind":"person","name":"ADAMS THOMAS PHD","position":1,"cik":"0001234366","reported_name":"ADAMS THOMAS PHD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-04T17:01:26.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest on January 2, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-000633","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234366/000110465917000633/a4.xml","form_type":"4"}}]}